What is a kernicterus settlement?
A kernicterus settlement compensates a child for permanent brain damage caused by untreated newborn jaundice, the toxic buildup of bilirubin that could almost always have been prevented by routine monitoring and standard treatment. Because kernicterus is considered a “never event” in modern medicine, these cases often present unusually strong liability.
That is the feature that sets kernicterus apart from most birth injuries. Where an HIE or cerebral palsy case can turn on a hard-fought argument about whether an injury was preventable at all, kernicterus in a full-term or near-term baby is widely regarded as preventable through inexpensive, universally available care: measuring bilirubin, plotting it on a risk chart, and treating with phototherapy or, if needed, exchange transfusion before the level becomes neurotoxic. When a hospital misses that, the “could this have been avoided?” question — the one that usually decides birth injury cases — often answers itself.
Why near-total preventability strengthens liability
Liability in any malpractice case has two parts: did the care fall below the standard, and did that failure cause the harm. Kernicterus tends to be strong on both.
The standard of care is clear and well published. The American Academy of Pediatrics sets out specific steps for screening and managing newborn hyperbilirubinemia (high bilirubin), including risk assessment before discharge, bilirubin measurement plotted against age in hours, timely follow-up, and treatment thresholds. Deviations (discharging a visibly jaundiced baby without a bilirubin level, failing to arrange follow-up, or not escalating a dangerously high number) are measurable departures from a written guideline, which is far easier to prove than a judgment call in a chaotic delivery. Causation is comparatively clean too: kernicterus has a characteristic clinical and MRI signature, and the mechanism (bilirubin crossing into the brain) is well understood. Learn more about the condition itself on our kernicterus page.
The lifetime harm being compensated
Classic kernicterus (kernicterus spectrum disorder) typically causes a devastating, permanent constellation: a movement disorder called dyskinetic (athetoid) cerebral palsy, hearing loss or auditory neuropathy, problems with upward gaze, and dental enamel defects. Cognition is often relatively preserved, which is its own cruelty: many affected children understand far more than their bodies can express. The care needs are lifelong and substantial: communication devices, hearing intervention, physical and occupational therapy, adaptive equipment, and often attendant care. That lifetime need, priced in a life care plan, is what a settlement must fund.
What drives the value of a case
| Factor | Why it moves the number |
|---|---|
| Liability clarity | Departures from published AAP jaundice-management guidelines are often documentable in the chart, making these cases comparatively strong on negligence. |
| Severity of impairment | The extent of the movement disorder, hearing loss, and functional limitation sets the scale of lifetime care. |
| Peak bilirubin and timing | How high the level rose and how long it stayed there before treatment supports both causation and the failure-to-treat narrative. |
| Life expectancy and care model | As in any severe birth injury case, projected years of life and the attendant-care model drive the largest line items in the plan. |
| Preserved cognition | A child who is cognitively intact but physically dependent may need extensive communication technology and support, and has a fuller awareness of the loss. |
| State law and defendant | Damages caps, hospital versus individual coverage, and federal-hospital rules apply as in any malpractice claim. |
Where the negligence usually lies
Kernicterus claims tend to cluster around a few recognized failures: discharging a newborn (often early, at 24–48 hours) without a pre-discharge bilirubin measurement or risk assessment; failing to arrange or ensure timely follow-up for a baby at risk; dismissing visible jaundice or worried parents’ reports without testing; not treating a bilirubin level that had crossed the phototherapy or exchange-transfusion threshold; and gaps in communication between the hospital, pediatrician, and family after discharge. Because the AAP guideline is explicit about each of these steps, the chart usually shows plainly whether they happened.
Publicly reported results
Kernicterus is rare, and most resolved cases are confidential, so representative published figures are limited. Because kernicterus produces severe, lifelong disability much like other forms of dyskinetic cerebral palsy, the damages scale is comparable to settlements in severe cerebral palsy cases: the life care plan can run into the millions or tens of millions in permanent cases, while the liability picture is often stronger because of the condition’s preventability.
Rather than cite a single figure as typical, we describe the range this way: severe permanent kernicterus cases are valued on the same lifetime-care basis as severe CP, and the unusually clear liability can affect how and when a defendant chooses to resolve them. Any specific number depends entirely on the child’s condition, the state’s law, and the strength of the records, and prior results do not guarantee or predict any future outcome.
Was your baby’s bilirubin checked before discharge — and was a dangerous level treated in time? Those questions are answerable from the newborn records, and in kernicterus cases the answers are often decisive. Our review costs your family nothing.
How the number is built
The damages are assembled like any severe birth injury case: a life care plan itemizes lifetime medical care, therapy, hearing and communication technology, equipment, attendant care, and home modification, priced with replacement cycles and reduced to present value by an economist, who also projects lost earning capacity. Non-economic damages for the child’s suffering and lost function are added under state law. What is often different in kernicterus is the liability side of the equation: with a documentable guideline violation, the discount both sides apply for the risk of losing on negligence can be smaller than in a hotly contested causation case, though causation and damages are still contested like any case.
State law and deadlines
State law governs kernicterus cases as it does all malpractice: non-economic damages caps in states such as California and Texas, none in New York and Pennsylvania, and a statute of limitations that varies by state. Children’s claims are frequently paused, but parents’ claims and public-hospital notice deadlines can expire within one to two years, worth confirming early.
Who would handle your case
It depends on where the newborn care was given. Banville Law attorneys are licensed in New York and Washington, D.C.; The Weitz Firm attorneys are licensed in Pennsylvania and New Jersey. In other states, the alliance connects families with its vetted network of local birth injury attorneys, and care at military or federally funded hospitals proceeds under the Federal Tort Claims Act.
Frequently asked questions
Why are kernicterus cases considered strong?
Because kernicterus in a term baby is regarded as almost entirely preventable with routine bilirubin monitoring and standard treatment. When those published steps are skipped, the negligence is often documentable in the chart, which makes the “was it preventable” question easier to answer than in most birth injury cases.
How much is a kernicterus settlement?
There is no reliable published average, but because kernicterus causes severe, permanent disability, the damages are valued on the same lifetime-care basis as severe cerebral palsy, potentially millions in permanent cases. The exact figure depends on the child’s condition, the records, and state law.
Our baby was discharged without a bilirubin test. Does that matter?
It can matter a great deal. Pre-discharge bilirubin risk assessment is part of the published standard of care. A newborn discharged with visible jaundice and no bilirubin level, who later developed kernicterus, raises a serious standard-of-care question the records can address.
What will a case cost us?
Nothing up front. These cases are handled on contingency: the firm advances the costs, and fees come only from a recovery.
Sources
- American Academy of Pediatrics. Clinical Practice Guideline for the Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3) (revised guideline).
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2004;114(1):297–316.
- Bhutani VK, Johnson L. Kernicterus in the 21st century: frequency and outcomes. Journal of Perinatology. 2009.
- Centers for Disease Control and Prevention. Facts about Jaundice and Kernicterus.
This page is for general education and is not legal or medical advice. Results are described in ranges for honesty; prior results do not guarantee or predict a similar outcome. Every case depends on its own facts. Reviewed by Laurence P. Banville, Esq. and Max Morgan, Esq.